Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Februar 2025 11:00 ET | Quelle: Zhittya Genesis Medicine Inc

Zhittya Genesis Medicine Announces: Landmark fMRI Study Reveals 21.2% Boost in Brain Blood Flow in Parkinson’s Patient Following Six Months of Intranasal FGF-1 Therapy

Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.
15. August 2023 08:00 ET | Quelle: Zhittya Genesis Medicine Inc

Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment?

LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...
09. Februar 2022 06:45 ET | Quelle: Brooks Rehabilitation

MagTrack Technology Opens Doors for Independent Operation of Smartphones, Computers, Other Devices for Wheelchair Users

JACKSONVILLE, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Brooks Rehabilitation is pleased to announce the MagTrack study, a collaborative research endeavor between Brooks and the Georgia Tech School of...
28. Mai 2015 14:48 ET | Quelle: Ent and Allergy

ENT and Allergy Associates(R) Announce ImThera Medical Clinical Study

TARRYTOWN, N.Y., May 28, 2015 (GLOBE NEWSWIRE) -- The following is a message from Dr. Ofer Jacobowitz, partner of ENT and Allergy Associates: Sleep apnea is a serious and dangerous disease where...